ENvue Medical, Inc. (FEED) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US63008J8844
ENvue Medical, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.55 m USD |
| Gross profit | 1.53 m USD |
| Operating income | -22.89 m USD |
| EBIT | -18.49 m USD |
| Net income | -18.19 m USD |
| Diluted EPS – continuing operations | -26.69 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ENvue Medical, Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.
More stocks
- Tanke Biosciences Corp (TNBI)
- Cardiff Lexington Corp (CDIX)
- MOBIX LABS, INC (MOBX)
- Longevity Health Holdings, Inc. (XAGE)
- ADVANCED OXYGEN TECHNOLOGIES INC (AOXY)
- ENCISION INC (ECIA)
- BIOADAPTIVES, INC. (BDPT)
- La Rosa Holdings Corp. (LRHC)
- Algorhythm Holdings, Inc. (RIME)
- Edible Garden AG Inc (EDBL)
- Jubilant Flame International, Ltd (JFIL)
- Functional Brands Inc. (MEHA)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.